Totus Medicines
2 known investors
Totus Medicines develops precision covalent small-molecule oral therapies aimed at historically "undruggable" and known disease targets, using its OmniDEL discovery platform that screens targets in their normal cellular environment. Its drug programs span oncology, immunology and inflammation, targeting patients with limited treatment options.
AI & Machine LearningBiotechHealthtech
Investors Β· 2
Frequently asked questions
- What does Totus Medicines do?
- Totus Medicines develops precision covalent small-molecule oral therapies aimed at historically "undruggable" and known disease targets, using its OmniDEL discovery platform that screens targets in their normal cellular environment. Its drug programs span oncology, immunology and inflammation, targeting patients with limited treatment options.
- Who are Totus Medicines's investors?
- Totus Medicines's investors include DCVC (Data Collective), Social Impact Capital.